AAPL338.40-2.67 (-0.78%) ▼|ABBV266.28+1.94 (+0.73%) ▲|ABT100.98-0.31 (-0.31%) ▼|ACN174.47-1.64 (-0.93%) ▼|ADBE231.01-4.46 (-1.89%) ▼|AMAT486.76+1.76 (+0.36%) ▲|AMD607.87-22.76 (-3.61%) ▼|AMGN418.13+3.52 (+0.85%) ▲|AMT168.00-1.03 (-0.61%) ▼|AMZN246.15-3.52 (-1.41%) ▼|AVGO349.57-3.24 (-0.92%) ▼|AXP306.33-2.56 (-0.83%) ▼|BA184.39-13.68 (-6.91%) ▼|BAC55.47-1.23 (-2.17%) ▼|BKNG163.87-0.08 (-0.05%) ▼|BLK1,071.25-15.06 (-1.39%) ▼|BMY63.88+1.02 (+1.62%) ▲|BNY148.44-1.71 (-1.14%) ▼|BRK-B503.09-2.39 (-0.47%) ▼|C131.31-2.97 (-2.21%) ▼|CAT819.95-1.63 (-0.20%) ▼|CL86.52+0.46 (+0.53%) ▲|CMCSA21.79-0.12 (-0.55%) ▼|COF196.46-3.74 (-1.87%) ▼|COP126.04-1.26 (-0.99%) ▼|COST922.92+0.16 (+0.02%) ▲|CRM227.27-6.75 (-2.88%) ▼|CSCO106.74+0.04 (+0.04%) ▲|CVS87.85-1.28 (-1.44%) ▼|CVX206.37+1.92 (+0.94%) ▲|DE689.59-0.87 (-0.13%) ▼|DHR227.33+2.84 (+1.27%) ▲|DIS105.59-0.56 (-0.53%) ▼|DUK113.41+0.06 (+0.05%) ▲|EMR159.39+1.16 (+0.73%) ▲|FDX289.65+3.80 (+1.33%) ▲|GD334.16-2.56 (-0.76%) ▼|GE318.24-8.85 (-2.71%) ▼|GEV949.77-7.86 (-0.82%) ▼|GILD152.21+1.28 (+0.85%) ▲|GM80.64-1.99 (-2.41%) ▼|GOOG339.16-1.92 (-0.56%) ▼|GOOGL342.75-1.17 (-0.34%) ▼|GS916.28-19.17 (-2.05%) ▼|HD289.89-3.31 (-1.13%) ▼|HON211.52-1.03 (-0.48%) ▼|IBM220.67-4.84 (-2.15%) ▼|INTC116.03-6.97 (-5.67%) ▼|INTU269.40-6.39 (-2.32%) ▼|ISRG414.79+9.61 (+2.37%) ▲|JNJ271.95+0.73 (+0.27%) ▲|JPM336.59-6.47 (-1.89%) ▼|KO87.18-0.63 (-0.72%) ▼|LIN472.04+2.15 (+0.46%) ▲|LLY1,184.78+1.32 (+0.11%) ▲|LMT518.10-1.46 (-0.28%) ▼|LOW187.66-1.62 (-0.86%) ▼|LRCX314.47-0.74 (-0.23%) ▼|MA568.26+0.61 (+0.11%) ▲|MCD233.60-2.90 (-1.23%) ▼|MDLZ60.18-0.07 (-0.12%) ▼|MDT89.50+0.86 (+0.97%) ▲|META715.62-36.04 (-4.79%) ▼|MMM169.48-0.07 (-0.04%) ▼|MO69.13+0.31 (+0.45%) ▲|MRK148.69-0.09 (-0.06%) ▼|MS193.64-2.67 (-1.36%) ▼|MSFT509.22-6.95 (-1.35%) ▼|MU1,053.98-28.30 (-2.61%) ▼|NEE75.49-0.59 (-0.78%) ▼|NFLX69.23-1.92 (-2.69%) ▼|NKE36.39+0.64 (+1.79%) ▲|NOW131.45-4.17 (-3.07%) ▼|NVDA228.86+3.79 (+1.68%) ▲|ORCL132.60-4.50 (-3.28%) ▼|PEP128.50-0.13 (-0.10%) ▼|PFE28.72+0.05 (+0.17%) ▲|PG149.03+2.80 (+1.91%) ▲|PLTR187.48-2.19 (-1.15%) ▼|PM193.76+3.28 (+1.72%) ▲|QCOM187.48-14.49 (-7.17%) ▼|RTX187.66-1.74 (-0.92%) ▼|SBUX95.27+0.41 (+0.43%) ▲|SCHW98.30-0.73 (-0.74%) ▼|SO82.35-0.53 (-0.64%) ▼|SPG204.53-0.29 (-0.14%) ▼|T24.90-0.48 (-1.89%) ▼|TMO678.60+3.60 (+0.53%) ▲|TMUS166.45+1.02 (+0.62%) ▲|TSLA357.45-14.66 (-3.94%) ▼|TXN278.31+0.24 (+0.09%) ▲|UBER68.16-1.46 (-2.10%) ▼|UNH377.83+1.24 (+0.33%) ▲|UNP274.10+0.31 (+0.11%) ▲|UPS94.25+0.29 (+0.31%) ▲|USB58.78-0.55 (-0.93%) ▼|V367.74+0.36 (+0.10%) ▲|VZ46.68-0.40 (-0.85%) ▼|WFC80.81-2.16 (-2.60%) ▼|WMT108.73+0.75 (+0.69%) ▲|XOM162.52+1.93 (+1.20%) ▲|AAPL338.40-2.67 (-0.78%) ▼|ABBV266.28+1.94 (+0.73%) ▲|ABT100.98-0.31 (-0.31%) ▼|ACN174.47-1.64 (-0.93%) ▼|ADBE231.01-4.46 (-1.89%) ▼|AMAT486.76+1.76 (+0.36%) ▲|AMD607.87-22.76 (-3.61%) ▼|AMGN418.13+3.52 (+0.85%) ▲|AMT168.00-1.03 (-0.61%) ▼|AMZN246.15-3.52 (-1.41%) ▼|AVGO349.57-3.24 (-0.92%) ▼|AXP306.33-2.56 (-0.83%) ▼|BA184.39-13.68 (-6.91%) ▼|BAC55.47-1.23 (-2.17%) ▼|BKNG163.87-0.08 (-0.05%) ▼|BLK1,071.25-15.06 (-1.39%) ▼|BMY63.88+1.02 (+1.62%) ▲|BNY148.44-1.71 (-1.14%) ▼|BRK-B503.09-2.39 (-0.47%) ▼|C131.31-2.97 (-2.21%) ▼|CAT819.95-1.63 (-0.20%) ▼|CL86.52+0.46 (+0.53%) ▲|CMCSA21.79-0.12 (-0.55%) ▼|COF196.46-3.74 (-1.87%) ▼|COP126.04-1.26 (-0.99%) ▼|COST922.92+0.16 (+0.02%) ▲|CRM227.27-6.75 (-2.88%) ▼|CSCO106.74+0.04 (+0.04%) ▲|CVS87.85-1.28 (-1.44%) ▼|CVX206.37+1.92 (+0.94%) ▲|DE689.59-0.87 (-0.13%) ▼|DHR227.33+2.84 (+1.27%) ▲|DIS105.59-0.56 (-0.53%) ▼|DUK113.41+0.06 (+0.05%) ▲|EMR159.39+1.16 (+0.73%) ▲|FDX289.65+3.80 (+1.33%) ▲|GD334.16-2.56 (-0.76%) ▼|GE318.24-8.85 (-2.71%) ▼|GEV949.77-7.86 (-0.82%) ▼|GILD152.21+1.28 (+0.85%) ▲|GM80.64-1.99 (-2.41%) ▼|GOOG339.16-1.92 (-0.56%) ▼|GOOGL342.75-1.17 (-0.34%) ▼|GS916.28-19.17 (-2.05%) ▼|HD289.89-3.31 (-1.13%) ▼|HON211.52-1.03 (-0.48%) ▼|IBM220.67-4.84 (-2.15%) ▼|INTC116.03-6.97 (-5.67%) ▼|INTU269.40-6.39 (-2.32%) ▼|ISRG414.79+9.61 (+2.37%) ▲|JNJ271.95+0.73 (+0.27%) ▲|JPM336.59-6.47 (-1.89%) ▼|KO87.18-0.63 (-0.72%) ▼|LIN472.04+2.15 (+0.46%) ▲|LLY1,184.78+1.32 (+0.11%) ▲|LMT518.10-1.46 (-0.28%) ▼|LOW187.66-1.62 (-0.86%) ▼|LRCX314.47-0.74 (-0.23%) ▼|MA568.26+0.61 (+0.11%) ▲|MCD233.60-2.90 (-1.23%) ▼|MDLZ60.18-0.07 (-0.12%) ▼|MDT89.50+0.86 (+0.97%) ▲|META715.62-36.04 (-4.79%) ▼|MMM169.48-0.07 (-0.04%) ▼|MO69.13+0.31 (+0.45%) ▲|MRK148.69-0.09 (-0.06%) ▼|MS193.64-2.67 (-1.36%) ▼|MSFT509.22-6.95 (-1.35%) ▼|MU1,053.98-28.30 (-2.61%) ▼|NEE75.49-0.59 (-0.78%) ▼|NFLX69.23-1.92 (-2.69%) ▼|NKE36.39+0.64 (+1.79%) ▲|NOW131.45-4.17 (-3.07%) ▼|NVDA228.86+3.79 (+1.68%) ▲|ORCL132.60-4.50 (-3.28%) ▼|PEP128.50-0.13 (-0.10%) ▼|PFE28.72+0.05 (+0.17%) ▲|PG149.03+2.80 (+1.91%) ▲|PLTR187.48-2.19 (-1.15%) ▼|PM193.76+3.28 (+1.72%) ▲|QCOM187.48-14.49 (-7.17%) ▼|RTX187.66-1.74 (-0.92%) ▼|SBUX95.27+0.41 (+0.43%) ▲|SCHW98.30-0.73 (-0.74%) ▼|SO82.35-0.53 (-0.64%) ▼|SPG204.53-0.29 (-0.14%) ▼|T24.90-0.48 (-1.89%) ▼|TMO678.60+3.60 (+0.53%) ▲|TMUS166.45+1.02 (+0.62%) ▲|TSLA357.45-14.66 (-3.94%) ▼|TXN278.31+0.24 (+0.09%) ▲|UBER68.16-1.46 (-2.10%) ▼|UNH377.83+1.24 (+0.33%) ▲|UNP274.10+0.31 (+0.11%) ▲|UPS94.25+0.29 (+0.31%) ▲|USB58.78-0.55 (-0.93%) ▼|V367.74+0.36 (+0.10%) ▲|VZ46.68-0.40 (-0.85%) ▼|WFC80.81-2.16 (-2.60%) ▼|WMT108.73+0.75 (+0.69%) ▲|XOM162.52+1.93 (+1.20%) ▲|
16.1 C
New York
Tuesday, September 29, 2026

Tag: company

newssourceFORcompanyinformationcontent1releasesmarket

Decisions taken by Suominen Corporation’s Extraordinary General Meeting

Suominen Corporation’s stock exchange release on June 8, 2026, at 10:30 a.m. (EEST)

LG Teams with NVIDIA to Shape the Future with M.A.P. (Mobility / AI Infra / Physical AI)

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- LG and NVIDIA are expanding their strategic collaboration across industries, Physical AI, AI Infra and mobility...

Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026

Basel, June 8th, 2026 – Novartis will present data from 10 abstracts at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026, spanning Rhapsido®  (remibrutinib) clinical trial results and real-world evidence on patient burden and treatment experience. Highlights include two late-breaking oral presentations; the Phase III RemIND trial for Rhapsido in chronic inducible urticaria (CIndU) and extension data from the Phase IIIb REMIXED trial in chronic spontaneous urticaria (CSU).

“The Rhapsido presentations at EAACI 2026 expand our understanding of BTK inhibition across multiple immune-mediated diseases and provide evidence of its potential to make a meaningful impact for patients who continue to face significant burden and limited treatment options,” said Angelika Jahreis, Global Head, Immunology Development, Novartis. “Novartis will present Rhapsido data from a long-term extension trial in chronic spontaneous urticaria, Phase III data in three types of chronic inducible urticaria, and early Phase II dose-response analysis for food allergy – together providing scientific evidence for its impact across numerous diseases.”

Abstracts accepted by EAACI include: 

Solidion Technology Granted 7 New Patents on Composite Anode Materials For Batteries Targeting Humanoid Robots, Space-Based Artificial Intelligence Data Centers and the Lunar Economy

 The newly granted patents further strengthen an already globally leading portfolio of patents on anode materials for high-energy and fast-charging lithium batteriesDALLAS, June 8,...

Tethis to launch SmartBioSurface® slides at EACR Conference

MILAN, June 8, 2026 /PRNewswire/ -- Tethis S.p.A., a pioneering life sciences and diagnostics company, today announces the commercial launch of SmartBioSurface slides, an...

Millions of students are finishing school this summer. Many still don’t know what’s next.

A Gap Year or Academic Year abroad is far more than a year off, it's an opportunity for young people to gain life experience and improve language skills.

NBPE Announces Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

Classico Pokemon Collection: “Stay with Your Favorite Pokemon Everywhere”

TOKYO, June 8, 2026 /PRNewswire/ -- Classico, Inc., a Japanese medical apparel brand headquartered in Tokyo, launched the highly anticipated #ClassicoPokemonCollection across the Asian...

FLSmidth: Transactions under share buy-back programme

COMPANY ANNOUNCEMENT NO. 29-2026
FLSmidth & Co. A/S
8 June 2026
Copenhagen, Denmark

Dong Bang Co Ltd Strengthens Global Competitiveness with Advanced Veterinary Pharmaceuticals

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dong Bang Co Ltd is strengthening its position in the global veterinary pharmaceutical market with high-value...

Clear Robotics Lands $1.75M to Build the World’s Largest Fleet of Zero-Emission Autonomous Ships

HONG KONG, June 8, 2026 /PRNewswire/ -- Today, Clear Robotics, a Hong Kong founded maritime technology company, announced that it closed a $1.75 million...

Carnegie Mellon Alumna Earns Tony Award for Best Musical

CMU alumni recognized with 67 Tonys to date — onstage and behind the scenes NEW YORK and PITTSBURGH, June 8, 2026 /PRNewswire/ -- Carnegie...

Camel Energy GmbH Showcases Advanced Battery Technologies at AABC Europe 2026

MAINZ, Germany, June 8, 2026 /PRNewswire/ -- Camel Energy GmbH proudly participated in the Advanced Automotive Battery Conference (AABC Europe 2026), held in Mainz, Germany,...

ROSEN, LEADING INVESTOR COUNSEL, Encourages Calix, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CALX

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Calix, Inc. (NYSE: CALX) between January 28, 2026 and April 21, 2026, inclusive (the “Class Period”), of the important July 27, 2026 lead plaintiff deadline.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers